Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.
Results from the TAGS study demonstrate safety and efficacy of
Surprise Finding Shows That Neutrophils Can Be Key Antitumor
Cancer discovery could revive failed treatments for solid tumours
Stress-tolerant cells drive tumour initiation in pancreatic cancer
Scientists unravel tumor neutrophil complexity, discover
Positive results from pivotal phase 3 trial evaluating nivolumab
Researchers uncover potential biomarkers of positive response to
Scientists unravel tumor neutrophil complexity, discover
Turbocharging the killing power of immune cells against cancer